Inari Medical Total Assets 2019-2024 | NARI
Inari Medical total assets from 2019 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Inari Medical Annual Total Assets (Millions of US $) |
|
|---|---|
| 2023 | $674 |
| 2022 | $504 |
| 2021 | $312 |
| 2020 | $214 |
| 2019 | $45 |
| 2018 | $0 |
| Inari Medical Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | $697 |
| 2024-06-30 | $673 |
| 2024-03-31 | $662 |
| 2023-12-31 | $674 |
| 2023-09-30 | $549 |
| 2023-06-30 | $525 |
| 2023-03-31 | $507 |
| 2022-12-31 | $504 |
| 2022-09-30 | $488 |
| 2022-06-30 | $484 |
| 2022-03-31 | $484 |
| 2021-12-31 | $312 |
| 2021-09-30 | $292 |
| 2021-06-30 | $254 |
| 2021-03-31 | $235 |
| 2020-12-31 | $214 |
| 2020-09-30 | $206 |
| 2020-06-30 | $224 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2018-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.990B | $0.494B |
| Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.480B | 24.70 |
| Intuitive Surgical (ISRG) | United States | $196.045B | 102.50 |
| Alcon (ALC) | Switzerland | $42.794B | 28.63 |
| Edwards Lifesciences (EW) | United States | $42.188B | 26.79 |
| IQVIA Holdings (IQV) | United States | $36.777B | 20.26 |
| IDEXX Laboratories (IDXX) | United States | $35.676B | 42.01 |
| DexCom (DXCM) | United States | $30.357B | 45.72 |
| Waters (WAT) | United States | $22.803B | 33.72 |
| STERIS (STE) | Ireland | $21.310B | 24.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.157B | 0.00 |
| Hologic (HOLX) | United States | $17.098B | 18.47 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.119B | 14.49 |
| Sysmex ADR (SSMXY) | Japan | $13.255B | 0.00 |
| Globus Medical (GMED) | United States | $11.345B | 28.73 |
| Penumbra (PEN) | United States | $9.105B | 89.18 |
| Masimo (MASI) | United States | $9.091B | 43.99 |
| Teleflex (TFX) | United States | $8.576B | 13.68 |
| Glaukos (GKOS) | United States | $7.735B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.949B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.675B | 26.50 |
| Veracyte (VCYT) | United States | $3.420B | 102.63 |
| LivaNova (LIVN) | United Kingdom | $2.699B | 15.58 |
| Nihon Kohden (NHNKY) | Japan | $2.361B | 17.93 |
| TransMedics (TMDX) | United States | $2.291B | 72.62 |
| Elekta AB (EKTAY) | Sweden | $2.165B | 19.47 |
| Tandem Diabetes Care (TNDM) | United States | $1.978B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| RxSight (RXST) | United States | $1.739B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.365B | 0.00 |
| Artivion (AORT) | United States | $1.243B | 82.39 |
| Pulse Biosciences (PLSE) | United States | $1.215B | 0.00 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.849B | 14.43 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.712B | 0.00 |
| IRadimed (IRMD) | United States | $0.687B | 37.11 |
| Mesa Laboratories (MLAB) | United States | $0.674B | 15.88 |
| AxoGen (AXGN) | United States | $0.656B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.561B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.512B | 30.12 |
| Treace Medical Concepts (TMCI) | United States | $0.494B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.439B | 23.75 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| NeuroPace (NPCE) | United States | $0.337B | 0.00 |
| CVRx (CVRX) | United States | $0.327B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.284B | 0.00 |
| Inogen (INGN) | United States | $0.226B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Accuray (ARAY) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.174B | 0.00 |
| Nevro (NVRO) | United States | $0.157B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.145B | 15.49 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.095B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| 908 Devices (MASS) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |